|
A.B. Vereide, M. Arnes, B. Straume, J.M. Maltau, A. Ørbo. Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasi. A pilot study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone.
Gynecological Oncology
Anne Ørbo, M.N. Nilsen, M.S. Arnes, I. Pettersen, K. Larsen.Expresseion of MLH1, MSH2, MSH6 and PTEN related to cancer development or coexistent cancer in 68 patients with endometrial hyperplasia and known follow-up
International Journal of Gynecological Pathology
Anne Ørbo, M. Rydningen, B. Straume, S. Lysne Significance of morphometric DNA cytometric features anfd other prognostic markers on survival of endometrial cancer patients in Northern Norway.
International JournaL OF Gynecological Cancer
Anne Ørbo, K. Eklo, M. Kopp, B. Straume.A semiautomated test for microsattelite instability and its significance for prognosis of sporadic endometrial cancer in Northern Norway
Journal of Gynecological Pathology
Jan P.A.Baak, A. Ørbo, M.A.M. Broeckaert, P.J. Diest, et al. Prospective nulticenter long-term evaluation of the computerized morphometric D-score to predict the outcome of endometrial hyperplasias.
American Journal of Surgery Pathology
Anne Ørbo, P.A.Baak, I. Kleivan, S. Lysne, P.S. Prytz, M.A.M. Broeckaert, A. Slappendel, H. J. Tichelaar Computerized morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long term retrospective study from Northern Norway.
Journal of Clinical Pathology
A.B. Vereide, M. Arnes, B. Straume, J.M. Maltau, A. Ørbo. Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasi. A pilot study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone.
Gynecological Oncology
Anne Ørbo, M.N. Nilsen, M.S. Arnes, I. Pettersen, K. Larsen.Expresseion of MLH1, MSH2, MSH6 and PTEN related to cancer development or coexistent cancer in 68 patients with endometrial hyperplasia and known follow-up
International Journal of Gynecological Pathology
Anne Ørbo, M. Rydningen, B. Straume, S. Lysne Significance of morphometric DNA cytometric features anfd other prognostic markers on survival of endometrial cancer patients in Northern Norway.
International JournaL OF Gynecological Cancer
Anne Ørbo, K. Eklo, M. Kopp, B. Straume.A semiautomated test for microsattelite instability and its significance for prognosis of sporadic endometrial cancer in Northern Norway
Journal of Gynecological Pathology
Jan P.A.Baak, A. Ørbo, M.A.M. Broeckaert, P.J. Diest, et al. Prospective nulticenter long-term evaluation of the computerized morphometric D-score to predict the outcome of endometrial hyperplasias.
American Journal of Surgery Pathology
Anne Ørbo, P.A.Baak, I. Kleivan, S. Lysne, P.S. Prytz, M.A.M. Broeckaert, A. Slappendel, H. J. Tichelaar Computerized morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long term retrospective study from Northern Norway.
Journal of Clinical Pathology
Dr. Ørbo A
Dirección profesional:
Dept of pathology, Institute of medical biology, medical Faculty, University of Tromsø, N-9037 Tromsø, Norway
|